Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial

INTRODUCTION: Over 70% of all hospital admissions have a peripheral intravenous device (PIV) inserted; however, the failure rate of PIVs is unacceptably high, with up to 69% of these devices failing before treatment is complete. Failure can be due to dislodgement, phlebitis, occlusion/infiltration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rickard, Claire M, Marsh, Nicole, Webster, Joan, Playford, E Geoffrey, McGrail, Matthew R, Larsen, Emily, Keogh, Samantha, McMillan, David, Whitty, Jennifer A, Choudhury, Md Abu, Dunster, Kimble R, Reynolds, Heather, Marshall, Andrea, Crilly, Julia, Young, Jeanine, Thom, Ogilvie, Gowardman, John, Corley, Amanda, Fraser, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Evidence Based Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593168/
https://www.ncbi.nlm.nih.gov/pubmed/26399574
http://dx.doi.org/10.1136/bmjopen-2015-008689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593168/
https://www.ncbi.nlm.nih.gov/pubmed/26399574
http://dx.doi.org/10.1136/bmjopen-2015-008689

Ejemplares similares